Member Exclusive

Cell therapy weekly: Yescarta “is not recommended” for NHS availability

This week: Kymriah receives European Commission approval and safety of MSC administration in ALS patients confirmed

Go to the profile of RegMedNet
Aug 30, 2018

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.